Skip to main content
James Rosenbaum, MD, Rheumatology, Portland, OR, VA Portland Healthcare System

JamesToddRosenbaumMD

Rheumatology Portland, OR

Professor, Ophthalmology, Oregon Health and Science University School of Medicine

Dr. Rosenbaum is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rosenbaum's full profile

Already have an account?

Education & Training

  • Stanford University
    Stanford UniversityFellowship, Immunology, 1978 - 1981
  • Stanford University
    Stanford UniversityResidency, Internal Medicine, 1975 - 1978
  • Yale University School of Medicine
    Yale University School of MedicineClass of 1975

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 1985 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
  • Elected Member The American Society for Clinical Investigation, 1994

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Community Profiling of the Urinary Microbiota: Considerations for Low-Biomass Samples  
    Rahel Nardos, James T Rosenbaum, Nature

Other

Press Mentions

  • Managing Ocular Disorders in Inflammatory Joint Disease: An Interdisciplinary Approach
    Managing Ocular Disorders in Inflammatory Joint Disease: An Interdisciplinary ApproachMarch 12th, 2019
  • The 2018 ACR Great Debate: Hydroxychloroquine Dosing for SLE
    The 2018 ACR Great Debate: Hydroxychloroquine Dosing for SLENovember 2nd, 2018
  • The Great Debate: Plaquenil - Choosing Safety over Efficacy?
    The Great Debate: Plaquenil - Choosing Safety over Efficacy?October 21st, 2018
  • Join now to see all

Grant Support

  • Ophthalmology Core FacilityNational Eye Institute1995–2012
  • Understanding Uveitis In A Multi-System Disease Model Of SpondyloarthropathyNational Eye Institute2011
  • Gene Expression In Nonspecific Orbital Inflammatory DiseaseNational Eye Institute2011
  • Endotoxin-Induced Uveitis RevisitedNational Eye Institute2009–2010
  • Four Dimensional Imaging Of The Immune Response In VivoNational Eye Institute1999–2010
  • Uveitis Gene-Expression ProfilingNational Eye Institute2005–2008
  • Chemotactic Factors In Animal Models Of UveitisNational Eye Institute1986–2008
  • Immunology/Molecular Biology Training In OphthalmologyNational Eye Institute1991–2007
  • Uveitis Gene-Expressoin ProfilingNational Eye Institute2006
  • "Remicade" In The Management Of Vision-Threatening UveitisNational Center For Research Resources2004–2005
  • Anterior Uveal Dendritic CellsNational Eye Institute2001–2004
  • Opthalmology Core FacilityNational Eye Institute2000–2004
  • Four Dimentional Imaging Of The Immune Response In VivoNational Eye Institute2000–2003
  • Chemotactic Factors In Models Of UveitisNational Eye Institute1994–2003
  • Ophthalmology Core Facility SupplementNational Eye Institute2001
  • Utility Of Intravenous Immunoglobulin In The Treatment Of UveitisNational Center For Research Resources1997–2001
  • Endotoxin Induced UveitisNational Eye Institute1985–2000
  • Core--Tissue CultureNational Eye Institute1997–1999
  • Endotoxin-Induced UveitisNational Eye Institute1987–1996
  • Growth Factors In Proliferative VitreoretinopathyNational Eye Institute1989–1992

Professional Memberships

Hospital Affiliations